Study Stopped
Recent publication makes current study obsolete.
Epiretinal Membrane and Pseudophakic Cystoid Macular Edema
Association of Cystoid Macular Edema After Cataract Surgery in Patients With and Without Epiretinal Membrane
1 other identifier
observational
52
1 country
1
Brief Summary
Prospective, observational cohort study evaluating the association between pre-surgical existence of an epiretinal membrane (ERM) and the development of pseudophakic cystoid macular edema (PCME) using spectral domain optical coherence tomography (OCT) measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 24, 2016
CompletedFirst Posted
Study publicly available on registry
February 26, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedMarch 19, 2019
March 1, 2019
3.1 years
February 24, 2016
March 17, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Cystoid Macular Edema diagnosed by OCT
Within 90 days post op
Study Arms (2)
Study Group
Patients with diagnosed epiretinal membrane undergoing cataract surgery.
Control Group
Patients without epiretinal membrane undergoing cataract surgery.
Eligibility Criteria
All patients over 18 who are undergoing cataract surgery at Loma Linda University Eye Institute
You may qualify if:
- years or older
- Cataract surgery patients
You may not qualify if:
- Pre-existing macular edema
- Choroidal neovascularization
- Uveitis
- Age-related macular degeneration
- Myopia \> 6 diopters
- Proliferative diabetic retinopathy
- Diabetics retinopathy great than mild in serverity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loma Linda University Medical Center
Loma Linda, California, 92354, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Sierpina, MD
Loma Linda University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 24, 2016
First Posted
February 26, 2016
Study Start
February 1, 2016
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
March 19, 2019
Record last verified: 2019-03